Scott Flora - Invuity Director

Director

Mr. Scott D. Flora is Interim President, Chief Executive Officer, Director of the Company. Mr. Flora is currently President of SFlora Consulting LLC. Mr. Flora served as the President, Chief Executive Office and a director of OmniGuide Inc., a medical device company, from October 2011 to April 2014. He served as the Global Business Unit President for the surgical device division of Covidien plc, a global healthcare products company, from November 2006 until June 2011. From 1994 through 2006, Mr. Flora served in numerous positions at Smith Nephew plc, a global medical technology company, including President and General Manager of the orthopedics reconstruction division, General Manager of the trauma and clinical therapies divisions, Senior Vice President of United States and Europe, Senior Vice President of Smith Nephew Healthcare, and Senior Vice President of the orthopedics division. Mr. Flora currently serves as the Executive Chairman of Conventus Orthopaedics, a medical device company focused on developing a broad platform of minimally invasive intramedullary devices to repair traumatic endbone fractures, where he has served since December 2015. Mr. Flora currently serves on the board of directors of AgNovos Healthcare, a bone health medical device company, where he has served since January 2014. From July 2015 to November 2016, Mr. Flora served on the board of directors of Cotera, an orthopedic joint implant company. From July 2015 to January 2017, Mr. Flora was an advisor to CT Innovations, Connecticuts strategic VC arm, where he assisted with three of their startups. From July 2015 to May 206, Mr. Flora served on the board of directors of NovaTract Surgical, a medical device company offering innovative technologies for minimally invasive surgeries. From July 2013 to January 2014 Mr. Flora served on the board of directors of Mako Surgical. From September 2011 until January 2013, since 2018.
Tenure 6 years
Phone415-665-2100
Webhttp://www.invuity.com

Invuity Management Efficiency

The company has return on total asset (ROA) of (39.66) % which means that it has lost $39.66 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (481.4) %, meaning that it created substantial loss on money invested by shareholders. Invuity's management efficiency ratios could be used to measure how well Invuity manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 34.66 M in liabilities. Invuity has a current ratio of 2.09, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Invuity until it has trouble settling it off, either with new capital or with free cash flow. So, Invuity's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Invuity sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Invuity to invest in growth at high rates of return. When we think about Invuity's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Vincent DecalfTernium SA ADR
57
Antonio MacielMarfrig Global Foods
N/A
Brad SauerTyson Foods
55
Leslie ThorntonCECO Environmental Corp
59
David McDonaldMarfrig Global Foods
N/A
Jeffrey SchomburgerTyson Foods
58
Allen RogersInsteel Industries
71
Rodrigo MarcalMarfrig Global Foods
N/A
Barbara TysonTyson Foods
71
Cheryl MillerTyson Foods
48
Richard WangCECO Environmental Corp
42
Leslie BrunCorning Incorporated
68
Deborah RiemanCorning Incorporated
71
Seung JangPOSCO Holdings
57
Mark WrightonCorning Incorporated
71
Jose MironMarfrig Global Foods
52
Marcia SantosMarfrig Global Foods
N/A
Jonathan MarinerTyson Foods
66
Rodrigo PinaTernium SA ADR
51
Wu SunPOSCO Holdings
61
Pamela CraigCorning Incorporated
64
Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity operates under Medical Instruments Supplies classification in USA and is traded on NASDAQ General Markets. It employs 161 people. Invuity (IVTY) is traded on NASDAQ Exchange in USA and employs 161 people.

Management Performance

Invuity Leadership Team

Elected by the shareholders, the Invuity's board of directors comprises two types of representatives: Invuity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Invuity. The board's role is to monitor Invuity's management team and ensure that shareholders' interests are well served. Invuity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Invuity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Gerberich, Vice President - Sales and Marketing
Douglas Heigel, VP of Operations
Daniel Wolterman, Director
Alex Vayser, Co-Founder and CTO
William Burke, Independent Director
Philip Sawyer, CEO and President and Director
Eric Roberts, Independent Director
Andrew Sale, Senior Vice President of Global Sales
Scott Flora, Director
Gregory Brown,
James Mackaness, CFO
Steve Annen, Vice President of Product Management and Strategy
Joseph Guido, Vice President of Business Development
Randall Lipps, Independent Director
Paul Davison, VP of RandD
Reza Zadno, Independent Director
Brett Robertson, Chief Business Officer, General Counsel
Gregory Lucier, Chairman of the Board
Marcia Fish, Chief Human Resource Officer

Invuity Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Invuity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Invuity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Invuity's short interest history, or implied volatility extrapolated from Invuity options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in Invuity Stock

If you are still planning to invest in Invuity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Invuity's history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Correlations
Find global opportunities by holding instruments from different markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum